These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3053178)

  • 1. The treatment of chronic pulmonary hypertension by vasodilators: hope and hesitation.
    Jezek V
    Eur Heart J; 1988 Sep; 9 Suppl J():1-6. PubMed ID: 3053178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of paediatric patients with pulmonary hypertension judged by responsiveness to vasodilators.
    Houde C; Bohn DJ; Freedom RM; Rabinovitch M
    Br Heart J; 1993 Nov; 70(5):461-8. PubMed ID: 8260279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of pulmonary hypertension with selective pulmonary vasodilators.
    Haj RM; Cinco JE; Mazer CD
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):88-95. PubMed ID: 16547439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary pulmonary hypertension. An overview with special reference to risk-benefit analysis of therapy].
    Schilling W
    Z Erkr Atmungsorgane; 1991; 177(3):117-34. PubMed ID: 1808861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical results after vasodilator evaluation in patients with primary (unexplained) and secondary precapillary pulmonary hypertension: acute hemodynamic comparisons and long-term survival.
    McKay CR; Brundage BH; Ports TA; Parmley WW; Chatterjee K
    Int J Cardiol; 1989 Mar; 22(3):311-9. PubMed ID: 2651327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials with long-term treatment of pulmonary hypertension due to lung disease.
    Denolin H
    Eur Heart J; 1988 Sep; 9 Suppl J():29-32. PubMed ID: 3053182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilators ineffective in secondary pulmonary hypertension.
    Dash H; Ballentine N; Zelis R
    N Engl J Med; 1980 Oct; 303(18):1062-3. PubMed ID: 7421904
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vasodilators in "primary" pulmonary hypertension?].
    Morpurgo M
    G Ital Cardiol; 1990 Feb; 20(2):123-25. PubMed ID: 2328865
    [No Abstract]   [Full Text] [Related]  

  • 9. The response to inhaled nitric oxide in patients with pulmonary artery hypertension is not masked by baseline vasodilator use.
    Krasuski RA; Wang A; Harrison JK; Tapson VF; Bashore TM
    Am Heart J; 2005 Oct; 150(4):725-8. PubMed ID: 16209974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial reversibility of chronic pulmonary hypertension caused by pulmonary thromboembolic disease.
    Dantzker DR; Bower JS
    Am Rev Respir Dis; 1981 Aug; 124(2):129-31. PubMed ID: 6789732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unpredictable response to vasodilator therapy in primary pulmonary hypertension.
    Schmiedt MI; Shettigar UR; Siddique M; Barbier G; Bialow M; Carranza S
    Int J Clin Pharmacol Ther; 1998 Aug; 36(8):435-40. PubMed ID: 9726697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The United States experience with the acute and chronic treatment of primary pulmonary hypertension.
    Weir EK
    Eur Heart J; 1988 Sep; 9 Suppl J():33-8. PubMed ID: 3053183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential hemodynamic response to vasodilators in a patient with pulmonary hypertension: case report.
    Zaloga GP; Hughes P; Cohen D; Chernow B; Rainey TG; Lake CR
    Mil Med; 1983 May; 148(5):426-9. PubMed ID: 6408523
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypoxic pulmonary hypertension: haemodynamic changes after oxygen and various vasodilators in the same patient at different time periods.
    Král H; Hamet A; Cernohorský D; Stásek J; Tilser P
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993; 36(4-5):317-24. PubMed ID: 8599074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the effects of vasodilator therapy in primary pulmonary hypertension. Experience in 7 cases].
    Lanzarini L; Gavazzi A; Mussini A; Graziano G; Campana C; Bargiggia G; Angoli L; Aimè E; Arbustini E; Montemartini C
    G Ital Cardiol; 1990 Feb; 20(2):114-22. PubMed ID: 2328864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of vasodilators in pulmonary hypertension: pulmonary vascular or peripheral vascular?
    Rich S
    Circ Heart Fail; 2009 Mar; 2(2):145-50. PubMed ID: 19808330
    [No Abstract]   [Full Text] [Related]  

  • 17. Should patients with pulmonary hypertension and increased pulmonary resistance be treated with vasodilators?
    Rich S
    Cardiovasc Clin; 1990; 21(1):265-74; discussion 275-6. PubMed ID: 2199052
    [No Abstract]   [Full Text] [Related]  

  • 18. Modulating the pulmonary circulation: an update.
    Dembinski R; Henzler D; Rossaint R
    Minerva Anestesiol; 2004 Apr; 70(4):239-43. PubMed ID: 15173703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension in systemic lupus erythematosus: effect of vasodilators on pulmonary hemodynamics.
    Mahowald ML; Weir EK; Ridley DJ; Messner RP
    J Rheumatol; 1985 Aug; 12(4):773-7. PubMed ID: 4057200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Do vasodilators have a role in the treatment of pulmonary hypertension in chronic obstructive bronchopneumopathies?].
    Weitzenblum E; Mammosser M
    Rev Mal Respir; 1985; 2(6):337-8. PubMed ID: 3835609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.